Remaining low in normal conditions, the mRNA expression of HAS3 has been reported as upregulated in AD skin conditions, simultaneously with well-recognized AD markers, i.e., CA2 and NELL2 [29,113]. This evidence concerns the gene CA2 and Alzheimer disease.